GSK3B and glioma: Glioma cell culture study showed that CELSR2 KD induced an upregulation of total GSK-3β (phosphorylated protein decrease) and phosphorylated β-catenin (total protein decrease), and a decrease of TCF/LEF activity, showing an inactive state of the Wnt-β-catenin signaling.